Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

p63 is essential for controlling epithelial stem cells and tissue health.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Balancing hormones can help women feel youthful and healthy.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.